(3S)-N-[(1S)-5-Amino-1-[[(2,2-diphenylethyl)amino]carbonyl]pentyl]-2-(1,4-dioxo-4-phenylbutyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide
![]() |
- $197 - $314
- Product name: (3S)-N-[(1S)-5-Amino-1-[[(2,2-diphenylethyl)amino]carbonyl]pentyl]-2-(1,4-dioxo-4-phenylbutyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide
- CAS: 914291-63-7
- MF: C40H44N4O4
- MW: 644.8
- EINECS:
- MDL Number:MFCD26793888
- Synonyms:(3S)-N-[(1S)-5-Amino-1-[[(2,2-diphenylethyl)amino]carbonyl]pentyl]-2-(1,4-dioxo-4-phenylbutyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide;VUF10661;3-Isoquinolinecarboxamide, N-[(1S)-5-amino-1-[[(2,2-diphenylethyl)amino]carbonyl]pentyl]-2-(1,4-dioxo-4-phenylbutyl)-1,2,3,4-tetrahydro-, (3S)-
2 prices
Selected condition:
Brand
- Sigma-Aldrich
Package
- 5mg
- 25mg
- ManufacturerSigma-Aldrich
- Product numberSML0803
- Product descriptionVUF10661 ≥98% (HPLC)
- Packaging5mg
- Price$197
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML0803
- Product descriptionVUF10661 ≥98% (HPLC)
- Packaging25mg
- Price$314
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich | SML0803 | VUF10661 ≥98% (HPLC) | 5mg | $197 | 2024-03-01 | Buy |
Sigma-Aldrich | SML0803 | VUF10661 ≥98% (HPLC) | 25mg | $314 | 2024-03-01 | Buy |
Properties
Boiling point :935.8±65.0 °C(Predicted)
Density :1.191±0.06 g/cm3(Predicted)
storage temp. :-20°C
solubility :DMSO: soluble10mg/mL, clear
pka :13.52±0.20(Predicted)
form :powder
color :white to beige
Density :1.191±0.06 g/cm3(Predicted)
storage temp. :-20°C
solubility :DMSO: soluble10mg/mL, clear
pka :13.52±0.20(Predicted)
form :powder
color :white to beige
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|